Jay A. Turpen

Jay Turpen.jpg

Senior Consultant

The Avoca Group

Jay Turpen is a Senior Consultant with The Avoca Group.  He has been in the pharmaceutical industry for 29 years and has held various leadership roles. Jay has a wealth of experience in GMP, GLP, and GCP environments with significant real-life experience in developing numerous new drug candidates. 
His pharma experience started in GMP of small molecule and large molecule (biologic) active pharmaceutical ingredients (API). Jay has been involved in leading multiple clinical teams responsible for the clinical development and NDA preparation for multiple molecules in osteoporosis, diabetes, cardiovascular, neuroscience, and immunology. Jay also led a transformation effort for his company’s CLO organization that effected processes, systems, job definitions/descriptions, and organizational leadership to meet both GLP and GCP requirements. 
Most recently, Jay was Senior Director for Clinical Project Management (CPM) where he was responsible for the clinical development for Alzheimer’s disease, autoimmune diseases, men’s health, pain, and other neuroscience indications. This CPM organization, under Jay’s leadership, successfully completed multiple NDA submissions, regulatory agency inspections, and received regulatory approvals for small molecule and biologic products demonstrating thorough GCP compliance. Jay retired from Eli Lilly & Co. at the end of 2017 where he was Sr. Director, Clinical Project Management - Biomedicines.